Halozyme Therapeutics shares owned by EFG Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by EFG Asset Management
from 13F filings
Historical chart of EFG Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by EFG Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by EFG Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $6.1M | 128k | 47.81 |
| 2024-09-30 | $6.2M | 108k | 57.22 |
| 2024-06-30 | $7.3M | 140k | 52.37 |
| 2024-03-31 | $5.7M | 140k | 40.64 |
| 2023-12-31 | $4.8M | 131k | 36.96 |
| 2023-09-30 | $5.3M | 138k | 38.21 |
| 2023-06-30 | $5.1M | 142k | 36.07 |
| 2023-03-31 | $4.4M | 116k | 38.18 |
| 2022-12-31 | $7.1M | 125k | 56.98 |
| 2022-09-30 | $6.0M | 151k | 39.54 |
| 2022-06-30 | $7.6M | 172k | 44.01 |
| 2022-03-31 | $12M | 294k | 39.87 |
| 2021-12-31 | $12M | 296k | 40.22 |